Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Association between weight gain and clinical outcomes among malnourished adults initiating antiretroviral therapy in Lusaka, Zambia.

Koethe JR, Lukusa A, Giganti MJ, Chi BH, Nyirenda CK, Limbada MI, Banda Y, Stringer JS.

J Acquir Immune Defic Syndr. 2010 Apr 1;53(4):507-13. doi: 10.1097/QAI.0b013e3181b32baf.

2.

Early immunologic response and subsequent survival among malnourished adults receiving antiretroviral therapy in Urban Zambia.

Koethe JR, Limbada MI, Giganti MJ, Nyirenda CK, Mulenga L, Wester CW, Chi BH, Stringer JS.

AIDS. 2010 Aug 24;24(13):2117-21. doi: 10.1097/QAD.0b013e32833b784a.

3.

Nutrition and inflammation serum biomarkers are associated with 12-week mortality among malnourished adults initiating antiretroviral therapy in Zambia.

Koethe JR, Blevins M, Nyirenda C, Kabagambe EK, Shepherd BE, Wester CW, Zulu I, Chiasera JM, Mulenga LB, Mwango A, Heimburger DC.

J Int AIDS Soc. 2011 Apr 10;14:19. doi: 10.1186/1758-2652-14-19.

4.

Self-reported dietary intake and appetite predict early treatment outcome among low-BMI adults initiating HIV treatment in sub-Saharan Africa.

Koethe JR, Blevins M, Bosire C, Nyirenda C, Kabagambe EK, Mwango A, Kasongo W, Zulu I, Shepherd BE, Heimburger DC.

Public Health Nutr. 2013 Mar;16(3):549-58. doi: 10.1017/S1368980012002960.

5.

Short communication: Late refills during the first year of antiretroviral therapy predict mortality and program failure among HIV-infected adults in urban Zambia.

Vinikoor MJ, Schuttner L, Moyo C, Li M, Musonda P, Hachaambwa LM, Stringer JS, Chi BH.

AIDS Res Hum Retroviruses. 2014 Jan;30(1):74-7. doi: 10.1089/AID.2013.0167.

6.

CD4+ response and subsequent risk of death among patients on antiretroviral therapy in Lusaka, Zambia.

Chi BH, Giganti M, Mulenga PL, Limbada M, Reid SE, Mutale W, Stringer JS.

J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):125-31. doi: 10.1097/QAI.0b013e3181ab6d8b.

7.

Effects on mortality of a nutritional intervention for malnourished HIV-infected adults referred for antiretroviral therapy: a randomised controlled trial.

NUSTART (Nutritional Support for Africans Starting Antiretroviral Therapy) Study Team., Filteau S, PrayGod G, Kasonka L, Woodd S, Rehman AM, Chisenga M, Siame J, Koethe JR, Changalucha J, Michael D, Kidola J, Manno D, Larke N, Yilma D, Heimburger DC, Friis H, Kelly P.

BMC Med. 2015 Jan 28;13:17. doi: 10.1186/s12916-014-0253-8.

8.

Weight change at 1 mo of antiretroviral therapy and its association with subsequent mortality, morbidity, and CD4 T cell reconstitution in a Tanzanian HIV-infected adult cohort.

Sudfeld CR, Isanaka S, Mugusi FM, Aboud S, Wang M, Chalamilla GE, Giovannucci EL, Fawzi WW.

Am J Clin Nutr. 2013 Jun;97(6):1278-87. doi: 10.3945/ajcn.112.053728.

9.

Serum phosphate predicts early mortality in adults starting antiretroviral therapy in Lusaka, Zambia: a prospective cohort study.

Heimburger DC, Koethe JR, Nyirenda C, Bosire C, Chiasera JM, Blevins M, Munoz AJ, Shepherd BE, Potter D, Zulu I, Chisembele-Taylor A, Chi BH, Stringer JS, Kabagambe EK.

PLoS One. 2010 May 18;5(5):e10687. doi: 10.1371/journal.pone.0010687.

10.

Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.

Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, Mtonga V, Reid S, Cantrell RA, Bulterys M, Saag MS, Marlink RG, Mwinga A, Ellerbrock TV, Sinkala M.

JAMA. 2006 Aug 16;296(7):782-93.

PMID:
16905784
11.

Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.

Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM, Chi BH, Sinkala M, Kankasa C, Wilson CM, Wilfert CM, Mwango A, Levy J, Abrams EJ, Bulterys M, Stringer JS.

JAMA. 2007 Oct 24;298(16):1888-99.

PMID:
17954540
12.

Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia.

Chi BH, Cantrell RA, Zulu I, Mulenga LB, Levy JW, Tambatamba BC, Reid S, Mwango A, Mwinga A, Bulterys M, Saag MS, Stringer JS.

Int J Epidemiol. 2009 Jun;38(3):746-56. doi: 10.1093/ije/dyp004.

13.

Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia.

Mulenga LB, Kruse G, Lakhi S, Cantrell RA, Reid SE, Zulu I, Stringer EM, Krishnasami Z, Mwinga A, Saag MS, Stringer JS, Chi BH.

AIDS. 2008 Sep 12;22(14):1821-7. doi: 10.1097/QAD.0b013e328307a051.

14.
15.
16.

Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland.

Schöni-Affolter F, Keiser O, Mwango A, Stringer J, Ledergerber B, Mulenga L, Bucher HC, Westfall AO, Calmy A, Boulle A, Chintu N, Egger M, Chi BH; Swiss HIV Cohort Study.; IeDEA Southern Africa..

PLoS One. 2011;6(12):e27919. doi: 10.1371/journal.pone.0027919.

17.

Six-month gain in weight, height, and CD4 predict subsequent antiretroviral treatment responses in HIV-infected South African children.

Yotebieng M, Van Rie A, Moultrie H, Meyers T.

AIDS. 2010 Jan 2;24(1):139-46. doi: 10.1097/QAD.0b013e328332d5ca.

18.

Weight change after antiretroviral therapy and mortality.

Yuh B, Tate J, Butt AA, Crothers K, Freiberg M, Leaf D, Logeais M, Rimland D, Rodriguez-Barradas MC, Ruser C, Justice AC.

Clin Infect Dis. 2015 Jun 15;60(12):1852-9. doi: 10.1093/cid/civ192.

19.

Impact of malnutrition and social determinants on survival of HIV-infected adults starting antiretroviral therapy in resource-limited settings.

Argemi X, Dara S, You S, Mattei JF, Courpotin C, Simon B, Hansmann Y, Christmann D, Lefebvre N.

AIDS. 2012 Jun 1;26(9):1161-6. doi: 10.1097/QAD.0b013e328353f363.

PMID:
22472856
20.

Supplemental Content

Support Center